A critical discovery in cancer investigation is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This crucial tumor inhibitor protein is frequently disabled in several kinds of tumors, resulting https://atozbookmark.com/story21799443/nanobodies-restore-p53-a-new-pathway-for-cancer-treatment